Neurology News and Research

Latest Neurology News and Research

Broader use of psychological testing may improve process for social security disability determination

Broader use of standardized psychological testing for applicants submitting disability claims to the U.S. Social Security Administration should improve the accuracy and consistency of disability determinations, says a new report from the Institute of Medicine.

13 Apr 2015

Mindfulness meditation can reduce pain, anxiety in healthy individuals

When Rebecca Erwin was a varsity rower at the University of North Carolina, the coach had the team's members take a yoga and meditation class.

10 Apr 2015

Stroke patients can benefit from clot-busting drug, shows brain scan study

A drug that breaks up blood clots in the brains of stroke patients could be used more widely than at present without increased risk, a brain scan study suggests.

10 Apr 2015

Arts and craft activities, computer use may stave off memory problems

People who participate in arts and craft activities and who socialize in middle and old age may delay the development in very old age of the thinking and memory problems that often lead to dementia, according to a new study published in the April 8, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

9 Apr 2015

Stroke patients at greater risk of committing suicide compared with other population groups

Stroke patients can be up to twice as likely to commit suicide compared with the rest of the population, and the risk of attempted suicide is highest within the first two years after a stroke. These are the findings of a study from Umeå University published in the journal Neurology.

8 Apr 2015

TOAST classification remains effective, easy-to-use system to classify strokes

In 1993, neurologists Harold P. Adams Jr., MD, and Jose Biller, MD, and colleagues proposed a new way to classify strokes. It became known as the TOAST classification. Twenty-two years later, the TOAST classification remains an effective and easy-to-use system that is routinely employed in stroke studies around the world, Drs. Adams and Biller report in the journal Stroke, published online ahead of print.

8 Apr 2015

Deep brain stimulation reduces PD pain severity but does not prevent it

Subthalamic nucleus deep brain stimulation has a beneficial effect on pain severity in patients with Parkinson’s disease that persists for up to 8 years, say researchers, but new onset of musculoskeletal pain in many suggests its effects are not enduring.

7 Apr 2015

Bilirubin levels raised in newly diagnosed Parkinson’s disease

Bilirubin levels are upregulated in patients with early Parkinson’s disease and are associated with disease progression at 2 years, a study shows.

7 Apr 2015

New blood test may more accurately identify biomarkers for Parkinson's disease

A new blood test may more accurately identify blood signatures, or biomarkers, for Parkinson's disease (PD), according to a new study published in the journal Movement Disorders.

7 Apr 2015

Scientists identify small RNA molecule that can suppress cancer-causing genes in GBM

Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor.

6 Apr 2015

Depomed acquires U.S. rights to NUCYNTA franchise from Janssen Pharmaceuticals

Depomed, Inc. today announced that it has closed the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion. The NUCYNTA franchise includes: NUCYNTA ER (tapentadol) extended release tablets indicated for the management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN), severe enough to require daily, around-the-clock, long-term opioid treatment; NUCYNTA (tapentadol), an immediate release version of tapentadol, for management of moderate to severe acute pain in adults; and NUCYNTA (tapentadol) oral solution, an approved oral form of tapentadol that has not been launched.

6 Apr 2015

Researchers test effects of light therapy on brain function

Following up on promising results from pilot work, researchers at the VA Boston Healthcare System are testing the effects of light therapy on brain function in veterans with Gulf War Illness.

3 Apr 2015

Study: APOSEC protein concentrate reduces severity of damage after spinal cord injuries

In tests conducted on animals, the APOSEC protein concentrate extracted from white blood cells has reduced the severity of damage after an accident involving spinal cord injuries when the agent was injected in the abdominal cavity 40 minutes after the acute lesion. As a result, severe consequential paralyses can be prevented.

2 Apr 2015

Pouchlike structure inside the heart's left atrial chamber could cause strokes

A pouchlike structure inside the heart's left atrial chamber in some people may explain strokes that otherwise lack an identifiable cause, according to UC Irvine School of Medicine researchers.

2 Apr 2015

Northwestern Medicine opens multidisciplinary treatment center for patients battling Huntington's disease

Northwestern Medicine recently launched a multidisciplinary center dedicated to the comprehensive treatment of patients battling Huntington's disease. The new center will focus on both patient care and research of the inherited disease that causes the progressive breakdown of nerve cells in the brain.

31 Mar 2015

Study suggests possible role for caffeine in AD treatment

The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

31 Mar 2015

Aeterna Zentaris inks Material Transfer Agreement with MUSC

Aeterna Zentaris Inc. today announced that it has agreed to transfer its discovery library of roughly 100,000 unique compounds to the South Carolina Center for Therapeutic Discovery & Development (the Center) pursuant to a just concluded Material Transfer Agreement.

31 Mar 2015

Merck Serono, Intrexon partner to develop and commercialize CAR-T cancer therapies

Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation, today announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies.

30 Mar 2015

MDC scientists find solution to increase efficiency of precise genetic modifications

CRISPR-Cas9 is a powerful new tool for editing the genome. For researchers around the world, the CRISPR-Cas9 technique is an exciting innovation because it is faster and cheaper than previous methods. Now, using a molecular trick, Dr. Van Trung Chu and Professor Klaus Rajewsky of the Max Delbrück Center for Molecular Medicine Berlin-Buch and Dr. Ralf Kühn, MDC and Berlin Institute of Health, have found a solution to considerably increase the efficiency of precise genetic modifications by up to eightfold.

30 Mar 2015

New stent retriever device reduces stroke damage

Elizabeth Celli was experiencing a moderate-to-severe stroke when she arrived at Loyola University Medical Center's Emergency Department. Mrs. Celli was weak on her left side, had difficulty speaking and was unable to walk. But after being treated with a new device called a stent retriever, her symptoms dramatically reversed.

30 Mar 2015

Neurology News and Research

Latest Neurology News and Research

Broader use of psychological testing may improve process for social security disability determination

Mindfulness meditation can reduce pain, anxiety in healthy individuals

Stroke patients can benefit from clot-busting drug, shows brain scan study

Arts and craft activities, computer use may stave off memory problems

Stroke patients at greater risk of committing suicide compared with other population groups

TOAST classification remains effective, easy-to-use system to classify strokes

Deep brain stimulation reduces PD pain severity but does not prevent it

Bilirubin levels raised in newly diagnosed Parkinson’s disease

New blood test may more accurately identify biomarkers for Parkinson's disease

Scientists identify small RNA molecule that can suppress cancer-causing genes in GBM

Depomed acquires U.S. rights to NUCYNTA franchise from Janssen Pharmaceuticals

Researchers test effects of light therapy on brain function

Study: APOSEC protein concentrate reduces severity of damage after spinal cord injuries

Pouchlike structure inside the heart's left atrial chamber could cause strokes

Northwestern Medicine opens multidisciplinary treatment center for patients battling Huntington's disease

Study suggests possible role for caffeine in AD treatment

Aeterna Zentaris inks Material Transfer Agreement with MUSC

Merck Serono, Intrexon partner to develop and commercialize CAR-T cancer therapies

MDC scientists find solution to increase efficiency of precise genetic modifications

New stent retriever device reduces stroke damage

Aneuro: Solutions for in vivo Electrophysiology Recordings eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Neurology News and Research

Latest Neurology News and Research

Aneuro: Solutions for in vivo Electrophysiology Recordings eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in